EMA: GL on bioanalytical method validation Rev.1 [Regulatives / Guidelines]

posted by Ohlbe – France, 2014-09-19 21:20 (4298 d 12:08 ago) – Posting: # 13547
Views: 5,026

Dear Helmut,

❝ 2. Section 6 ‘Incurred samples reanalysis’

old

❝ The concentration obtained for the initial analysis and the concentration obtained by reanalysis should be within 20% of their mean […].

new

❝ The concentration obtained for the initial analysis and the concentration obtained by reanalysis should be within 20% of their mean […]. The following equation should be used for the cal­cu­lations:

                 (repeat value – initial value)

   %difference = ────────────────────────────── ×100

                      mean value


The text actually changed from
The concentration obtained for the initial analysis and the concentration obtained by reanalysis should be within 20% of their mean for at least 67% of the repeats

to

The percent difference between the initial concentration and the concentration measured during the repeat analysis should not be greater than 20% of their mean for at least 67 % of the repeats


which may be a bit clearer. The initial wording could be interpreted as allowing a 40 % deviation (20 % below the mean, 20 % above it).

❝ 3. Section 7.1.1.11. ‘Stability of the samples’

old

❝ In addition, long-term freezer stability should be studied at each temperature at which study samples will be stored. A bracketing approach may be considered.

new

❝ In addition, long-term freezer stability should be studied at each temperature at which study samples will be stored. A bracketing approach may be considered.


❝ But why #3? If one has already shown stability at –80 ℃ and –20 ℃ – intending to store samples at any temperature in between – that’s an unscientific formalism, IMHO (yes; I’m aware about some Crystal City Conference discussions).


This is only for large molecules (section 7 of the guideline), not small molecules. The deletion removes the contradiction between 7.1.1.11 (which allowed bracketing) and 4.1.9 (which allows bracketing for small molecules, but excludes it for large molecules). If I remember correctly the discussions in Brussels in 2010, this was due to possible problems with the structural conformation of proteins, right ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
414 visitors (0 registered, 414 guests [including 21 identified bots]).
Forum time: 09:29 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5